Skip to content
Loading…
Age-related macular degeneration (AMD) affects more than 5 million people around the world. And until now, no treatment could restore their vision. The Prima system, which was approved in Europe in July and is awaiting FDA clearance in the US, changes that. It combines a retinal…
To respect copyright, we link to the source rather than republishing the full text. Read the complete article on MIT Technology Review.